GLP4- NA-931 “BIOGLUTIDE”. 10mg
4th Generation GLP: Bioglutide (also known as NA-931) is an experimental research product developed for the treatment of obesity and type 2 diabetes. It functions as a first-in-class quadruple receptor agonist that stimulates: GLP-1 + GIP + GLUCAGON and IGF-1 receptors. Researched to eliminate, minimize muscle wasting in a calorie deficit state. Another critical feature that advances weight management research ahead of all other previous products.
AI Readiness
Good foundation, but some important product data is still missing.
78%